A pill containing antihypertensives and a statin, with or without aspirin, was associated with reduced functional decline, but not reduced cognitive decline, in those aged 65 years and older, ...

Older adults with depression are more than five times more likely to experience decline in activities of daily living and instrumental activities of daily living, a new study has found. Decline was ...

Please provide your email address to receive an email when new articles are posted on . Eli Lilly & Co.’s donanemab slowed cognitive and functional decline in people with early Alzheimer’s. The phase ...

Healthy aging induces parallel changes in brain functional activity and structural morphology, yet the interplay between ...

Low-grade inflammation contributes to age-related decline and impairment, but the precise pathways responsible for this inflammation and their impact on natural aging have until now remained elusive.

A polypill that targets vascular risk factors may help slow functional decline in older adults, new research suggests. However, an analysis from the International Polycap Study (TIPS-3) showed that ...

An experimental drug developed by Eli Lilly and Co. "significantly slowed cognitive and functional decline" in people with early symptomatic Alzheimer's disease, the company announced Wednesday. In ...

New research reveals that even modest daily walking can slow the buildup of Alzheimer’s-linked proteins and delay cognitive decline, giving older adults a realistic path to protect their memory and ...

A new research review published in BMC Nursing examines how nurses view older patients’ physical decline and frailty in nursing homes and home care settings versus how older adults themselves and ...

(RTTNews) - Eli Lilly and Company's (LLY), investigational drug donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer's disease (AD), according to ...